Products & safety
Dandruff and seborrheic dermatitis: flakes, inflammation, scalp care, and flares
On this page
Dandruff describes scalp flaking, sometimes with itching. Seborrheic dermatitis is a condition that can cause scaling and an inflamed rash on the scalp and other areas, including eyebrows, ears and the face. Seeing flakes does not establish which scalp condition is present.[2]
Similar appearances can have different explanations
| Observation or term | Useful explanation |
|---|---|
| Dandruff | Visible scalp flakes may accompany oily skin, hair-care habits or an underlying skin condition.[1] |
| Seborrheic dermatitis | Scaling and rash can affect several oil-rich areas, rather than only the scalp.[2] |
| Dry-looking flakes | Appearance alone does not prove that simple dry skin is the cause.[1] |
| Other scalp disorders | Psoriasis, eczema and fungal scalp infections can also produce flaking.[1] |
| Cradle cap | The infant form needs age-appropriate care; adult medicated-shampoo instructions do not automatically apply.[4] |
Age, location, and skin tone change what readers see
Seborrheic dermatitis may produce greasy scales, dry flakes or both. In darker skin, affected areas can look lighter, darker, pink or purple rather than conspicuously red. Description of redness alone can therefore miss part of the picture.[2]
In adults, the scalp, forehead, eyebrows and ears are common sites. Babies may have scalp scale or affected skin folds. Location and appearance help an assessment, but a photograph or a single symptom does not distinguish every overlapping condition.[2]
A proposed mechanism is not a cleanliness judgement
AAD describes a possible reaction involving normal skin yeast and sebum, the oil skin produces. Everyone can have the yeast while only some develop the condition. The response to an antifungal treatment is relevant, but does not explain every part of the disease process.[3]
The same source states that seborrheic dermatitis is not caused by unclean skin and is not an allergy. That does not mean every itchy scalp has this diagnosis: a different condition, including a product-related skin reaction, may still need consideration.[3]
The ingredient and instructions matter more than the word shampoo
Dandruff shampoos can contain ingredients with different jobs, such as reducing yeast or loosening scale. A regular cosmetic shampoo and a medicated product are not interchangeable categories. The selected AAD guidance describes treatment chosen for the scalp problem and its severity.[4]
Contact time, frequency and tolerance depend on the product and hair texture. Curly or coily hair may need a different washing pattern from straight or fine hair. Applying medicated shampoo mainly to the scalp can limit unnecessary drying of hair; follow the relevant label and care plan.[1]
Initial control and maintenance have different roles
Treatment aims to lessen scale, rash and itch, then reduce future flares. A clinician may use antifungal products or selected anti-inflammatory medicines. Site and age matter, and a product intended for one area is not automatically suitable for eyelids, facial skin or an infant.[4]
Adult routines should not be transferred to cradle cap. AAD describes infant care with baby shampoo and gentle removal of loosened scale, while discouraging adult dandruff shampoo for children. Baby-specific assessment is relevant if the pattern is concerning or the diagnosis uncertain.[4]
A workable routine allows for individual triggers
AAD describes gentle cleansing and avoiding irritating products as parts of skin care. Stress and cold, dry conditions can accompany flares, but triggers differ. A symptom diary can support a discussion without establishing that one recorded exposure caused the whole condition.[5]
A treatment plan can explain what to do during a flare and between flares. Repeatedly escalating products without checking the diagnosis may add irritation. Persistent or severe dandruff is a reason to seek assessment; the broader category of scalp disorders includes conditions this page only introduces.[5][1]
Infant cradle cap and adult recurring disease can have different courses
AAD describes infant seborrheic dermatitis as cradle cap, even when it extends beyond the scalp; it usually clears within months. Teenage or adult disease can recur over years. Psoriasis and seborrheic dermatitis can coexist, sometimes called sebopsoriasis. These distinctions explain why a scalp-treatment experience in one age group does not establish the diagnosis or expected course in another.[6]
A leave-on anti-inflammatory medicine has a different role from shampoo
Not every scalp treatment is an antifungal shampoo. In the US, roflumilast foam 0.3% is a prescription treatment for seborrheic dermatitis from age nine. The medicine blocks an enzyme called phosphodiesterase 4 (PDE4); the label says its precise therapeutic mechanism is not well defined. It is a leave-on topical preparation, not a shampoo or corticosteroid. Its foam, cream and swallowed formulations must not be treated as interchangeable. The foam has its own liver-disease, interaction and flammability precautions. Persistent symptoms are a reason to review the diagnosis and options with a clinician, rather than independently adding or switching prescription treatments.[7]
Evidence & uncertainty
The exact cause of seborrheic dermatitis is not settled. Yeast normally present on skin, skin oil and the skin’s reaction appear to contribute. This is not simply a sign of poor hygiene. Treatment can control symptoms and flares, but persistent or severe flaking deserves assessment for other causes.[3]
Selected-source overview · Independent review pendingPublished questions
Does a flaky scalp necessarily mean dry skin?
Selected-source overview · Independent review pending. Read the evidence context.
Flaking can accompany oily skin, scalp-care factors or several skin conditions.[1]
Evidence behind this answer
- How to treat dandruff
professional society patient explanation · 2023
Selected relevant official page passages inspected · Flaking, alternative scalp conditions, hair texture and product instructions
This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.
Can seborrheic dermatitis affect areas beyond the scalp?
Selected-source overview · Independent review pending. Read the evidence context.
Eyebrows, ears, the face and other areas can also be affected.[2]
Evidence behind this answer
- Seborrheic dermatitis: Signs and symptoms
professional society patient explanation · 2022
Selected relevant official page passages inspected · Locations, scale, infant presentation and variation across skin tones
This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.
Is seborrheic dermatitis caused by poor hygiene?
Selected-source overview · Independent review pending. Read the evidence context.
AAD says it is not caused by unclean skin.[3]
Evidence behind this answer
- Seborrheic dermatitis: Causes
professional society patient explanation · 2022
Selected relevant official page passages inspected · Uncertain cause, yeast/sebum and distinction from hygiene or allergy
This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.
Do all dandruff shampoos work in the same way?
Selected-source overview · Independent review pending. Read the evidence context.
Ingredients can have different roles, including controlling yeast or reducing scale.[4]
Evidence behind this answer
- Seborrheic dermatitis: Diagnosis and treatment
professional society patient explanation · 2024
Selected relevant official page passages inspected · Control versus maintenance, product roles, site/age differences and cradle cap
This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.
Should every hair type use the same dandruff-shampoo schedule?
Selected-source overview · Independent review pending. Read the evidence context.
Product directions, hair texture and tolerance matter.[1]
Evidence behind this answer
- How to treat dandruff
professional society patient explanation · 2023
Selected relevant official page passages inspected · Flaking, alternative scalp conditions, hair texture and product instructions
This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.
Can an adult dandruff routine simply be used for cradle cap?
Selected-source overview · Independent review pending. Read the evidence context.
Infant care needs an age-appropriate approach.[4]
Evidence behind this answer
- Seborrheic dermatitis: Diagnosis and treatment
professional society patient explanation · 2024
Selected relevant official page passages inspected · Control versus maintenance, product roles, site/age differences and cradle cap
This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.
Does a flare after improvement necessarily mean treatment never worked?
Selected-source overview · Independent review pending. Read the evidence context.
Flare control and maintaining control are different goals in a recurrent condition.[5]
Evidence behind this answer
- Seborrheic dermatitis: Self-care
professional society patient explanation · 2022
Selected relevant official page passages inspected · Gentle care, differing triggers and a flare plan
This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.
Must a seborrheic rash look bright red?
Selected-source overview · Independent review pending. Read the evidence context.
Skin tone can affect the colour and visibility of the rash.[2]
Evidence behind this answer
- Seborrheic dermatitis: Signs and symptoms
professional society patient explanation · 2022
Selected relevant official page passages inspected · Locations, scale, infant presentation and variation across skin tones
This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.
The improvement was measured against the same foam without the drug
In STRATUM, 79.5% of participants receiving roflumilast met the eight-week success definition, compared with 58.0% receiving vehicle foam without the active drug. Success meant clear or almost-clear skin plus a substantial improvement on the investigator’s scale; it did not mean a permanent cure. The trial enrolled people aged nine or older with moderate or severe disease. This manufacturer-funded comparison supports an effect beyond the foam base, while leaving unanswered how it compares with antifungal shampoos or performs over years.[8]
References
- How to treat dandruff
Professional society patient explanation
American Academy of Dermatology · Content/publication date: 2023
Accessed: 2026-10-07 UTC · Selected relevant official page passages inspected
Cited sections: Flaking, alternative scalp conditions, hair texture and product instructionsUpdated 11 December 2023. Ingredient listings are not treated as a universal current market inventory; no fixed wash schedule or broad comparative effectiveness claim.
- Seborrheic dermatitis: Signs and symptoms
Professional society patient explanation
American Academy of Dermatology · Content/publication date: 2022
Accessed: 2026-10-07 UTC · Selected relevant official page passages inspected
Cited sections: Locations, scale, infant presentation and variation across skin tonesUpdated 6 December 2022. Examples support literacy, not image-based diagnosis of every scalp disorder.
- Seborrheic dermatitis: Causes
Professional society patient explanation
American Academy of Dermatology · Content/publication date: 2022
Accessed: 2026-10-07 UTC · Selected relevant official page passages inspected
Cited sections: Uncertain cause, yeast/sebum and distinction from hygiene or allergyUpdated 6 December 2022. Proposed mechanisms remain explanations, not a complete causal model or evidence that every similar rash has the same cause.
- Seborrheic dermatitis: Diagnosis and treatment
Professional society patient explanation
American Academy of Dermatology · Content/publication date: 2024
Accessed: 2026-10-07 UTC · Selected relevant official page passages inspected
Cited sections: Control versus maintenance, product roles, site/age differences and cradle capUpdated 14 May 2024. Selected care categories; no adult drug dose, trial percentage, complete product inventory or direct transfer of adult products to infants.
- Seborrheic dermatitis: Self-care
Professional society patient explanation
American Academy of Dermatology · Content/publication date: 2022
Accessed: 2026-10-07 UTC · Selected relevant official page passages inspected
Cited sections: Gentle care, differing triggers and a flare planUpdated 6 December 2022. Trigger observations are not independent proof of causation or an assurance that stress reduction prevents every flare.
- Seborrheic Dermatitis: Overview
Professional patient explanation
AAD · Content/publication date: not stated
Accessed: 2026-10-13 UTC · Selected relevant page text, guideline passages, or publication abstract inspected
Cited sections: Infant cradle cap versus teenage/adult recurrent course and overlap with psoriasis - ZORYVE roflumilast topical foam 0.3%: US prescribing information
Approved medicine label
Arcutis Biotherapeutics / DailyMed · Content/publication date: 2026
Accessed: 2026-10-20 UTC · Fresh current original approved-label text read, updated October 7, 2026; prescribing information revised September 2026. Indication, preparation, mechanism, contraindication and fire warning inspected. Used for the actual US foam indication and formulation boundaries only, not a dose, application schedule or personal prescription choice.
Cited sections: Indication 1.1, description/mechanism and precautions; distinguish foam from cream and oral medicineUS preparation-specific label; prescription suitability requires clinical assessment.
- Roflumilast foam 0.3% for adolescent and adult patients with seborrheic dermatitis: randomized phase 3 trial
Original research
Blauvelt and colleagues · Content/publication date: 2024
Accessed: 2026-10-20 UTC · Fresh full original publisher article retrieved and selected abstract, methods, results, discussion and conflicts read. STRATUM, 457 participants, eight-week vehicle-controlled trial; no comparison with an antifungal shampoo. DOI/PMID verified. Original source discloses manufacturer funding and investigator relationships.
Cited sections: Abstract; methods, baseline disease and participants; primary week-eight result; discussion, limitations and conflictsManufacturer-funded trial; authors disclosed company relationships. Eight-week vehicle comparison, not a shampoo ranking.
Scope & review
- Population
- Adult scalp/skin literacy with explicitly separate infant context
- Exposure or intervention
- Flakes, rash, suspected mechanisms, shampoos, care and recurrence
- Comparison
- Dandruff appearance versus diagnosis; cosmetic versus medicated shampoo; flare control versus maintenance
- Outcomes
- Scale, itch, irritation, visible rash and treatment burden
- Timeframe
- Recurrent adult flares versus often temporary infant cradle cap
- Jurisdiction
- Selected US professional explanations; product ingredients, licensing and age instructions differ
Selected-source educational explanation. Official guidance, original study findings and editorial interpretation are distinguished. No exhaustive search, independent systematic synthesis or qualified medical review has been completed.
Sources checked on their individual access dates. Selected sources were checked; ongoing surveillance and qualified review have separate statuses on the coverage page.
Revision history
- 2026-10-08 UTC: Added a sourced explanation in a bounded ten-article batch; qualified review remains pending.
- 2026-10-13 UTC: Deepened categories, selected primary-source evidence, comparator interpretation and scientific uncertainty; preserved prior IDs and citations.
- 2026-10-20 UTC: Added selected-source foundational categories, practical interpretation and comparative evidence after a full twenty-target household/environment/sleep audit. Existing prose and anchors preserved; qualified review remains pending.
What this article still leaves open
- Current independent comparisons of topical treatments, including recurrence and adverse effects.
- Dedicated diagnosis and care pages for scalp fungal infection, contact allergy and other scalp disorders.
Suggest a correction
Submit a content correction to the editorial queue, or download a local note. Leave out personal medical details. Submitted text is stored privately with a browser receipt session and is visible to this browser and the editor. Clearing cookies removes access to your submission history. This is not an account or a medical service.
Your submitted corrections for this article
Explore the topic map
Browse the health domains connected to this article. The map also identifies topics whose articles remain unwritten.